DoW Prostate Cancer, Early Investigator Research Award
Closed Posted
- Opportunity number
- HT942526PCRPEIRA
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Science and Technology and other Research and Development
- Eligible applicants
-
- Unrestricted
- Points of contact
-
- eBRAP Help Desk help@ebrap.org (301) 682-5507
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Defense Health Agency is soliciting applications for the Fiscal Year 2026 Prostate Cancer Research Program Early Investigator Research Award to support early-stage investigators conducting prostate cancer research under experienced mentorship, with a pre-application deadline of August 12, 2026, and full applications due September 2, 2026.
Eligible applicants are early-career investigators possessing a doctoral degree or equivalent with fewer than three years of postdoctoral research experience at the application submission deadline, excluding clinical residency or clinical fellowship training. Applicants must be affiliated with eligible U.S. or foreign organizations. Cost-sharing is not required. The Defense Health Agency expects to award approximately $8.82 million across approximately 14 awards, with a total cost cap of $630,000 per award and a maximum performance period of 3 years. Awards will be made no later than September 30, 2027, with obligated funds expiring September 30, 2032.
All applications must address one of four FY26 Prostate Cancer Research Program Overarching Challenges: improving health and survivorship for prostate cancer patients, developing new treatments for lethal prostate cancer, enhancing clinical care with emphasis on high-risk populations, or defining the biology of prostate cancer progression. Applications must include at least one mentor demonstrating experience in prostate cancer research and successful mentorship. Applicants must submit a researcher development plan articulating an individualized strategy for acquiring necessary skills and expertise to complete the project and foster the principal investigator's career development. Clinical trials and painful animal research are prohibited. No salary support for mentors or other senior personnel except the principal investigator may be requested. Extramural organizations submit through Grants.gov; intramural Department of the Army organizations submit through eBRAP. Peer review occurs in November 2026, followed by programmatic review in March 2027. The funding opportunity is CFDA 12.420 (Military Medical Research and Development).
Synopsis
Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Early Investigator Research Award (EIRA) supports prostate cancer research conducted by investigators in the early stages of their careers with guidance from an experienced mentor. All applications must address one of the FY26 PCRP Overarching Challenges.
Distinctive Features:
· Early-Career Investigator: Serves as the principal investigator. Includes investigators possessing a doctoral degree or equivalent with fewer than three years of postdoctoral research experience at the application submission deadline, excluding clinical residency or clinical fellowship training.
· Mentorship: Applications must include at least one mentor who demonstrates experience in prostate cancer research and successful mentorship.
· Researcher Development Plan: Applications must include a researcher development plan articulating an individualized strategy for acquiring necessary skills, competence, and expertise to complete the project and foster the Principal Investigator's (PI's) career development
Files
| File | Type | Posted |
|---|---|---|
| HT942526PCRPEIRA_GG.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity